A Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps (Pharmacare PLC, Palestine) and Tamiflu® 75 mg Caps (Hoffmann-La Roche, Switzerland)
Condition:   HealthyInterventions:   Drug: Oseltamivir;   Drug: Tamiflu®Sponsors:   Genuine Research Center, Egypt;   Pharmacare PLC, PalestineCompleted - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2015 Category: Research Source Type: clinical trials